Dermatologic medical ozone therapy complications treated with hyperbaric oxygen | Canada Hyperbarics Skip to main content
Case Report Undersea Hyperb Med 2025

Dermatologic medical ozone therapy complications treated with hyperbaric oxygen

McCray P, Johnson-Arbor K — Undersea Hyperb Med, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case report of a 43-year-old female who developed dermatologic complications following medical ozone therapy.

What They Found

A 43-year-old female experienced worsening alopecia and scarring after receiving medical ozone injections to her temples and forehead for hair growth. She underwent surgical excision and a course of forty hyperbaric oxygen treatments, ultimately achieving acceptable cosmesis.

What This Means for Canadian Patients

Canadian patients considering medical ozone therapy should be aware of potential serious dermatologic complications like scarring and alopecia. Hyperbaric oxygen therapy may offer a treatment option for such adverse effects.

Canadian Relevance

This study does not have a direct Canadian connection.

Study Limitations

As a case report, the findings are limited to a single patient and may not be generalizable to a wider population.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 41429029
Year Published 2025
Journal Undersea Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Ozone; Female; Adult; Cicatrix; Alopecia; Embolism, Air; Forehead

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.